TSX:ONC 0.73 CAD -0.01 -0.68% Volume: 47,410 September 2, 2015
NASDAQ:ONCY 0.54 USD -0.02 -2.73% Volume: 150,723 September 2, 2015

For Investors

The Cutting Edge of Cancer Innovation

Oncolytics Biotech Inc. is a developer of oncolytic viruses as cancer therapeutics and is listed on the Toronto Stock Exchange (TSX:ONC) and the NASDAQ (NASDAQ:ONCY). In addition to the information available on this site, investors can access the Company’s regulatory filings on the SEDAR website at www.sedar.com and on the EDGAR website at www.sec.gov.


Access our quarterly and year-end financial statements, MD&A, information circulars and annual reports.

View Financials

Stock Information

View our stock charts and other information about our stock (TSX:ONC, NASDAQ:ONCY).

View Stock Information

Analyst Coverage

Find out which analysts and institutions provide coverage of Oncolytics.

View Analyst Coverage

Investor Presentation

Click here to load our most recent investor presentation.

View Presentation

Latest News

August 27, 2015 Oncolytics Biotech® Inc. Collaborators to Present Survival Data from REO 016 Study in Non-Small Cell Lung Cancer
August 26, 2015 Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Non-Small Cell Lung Cancer Study
August 12, 2015 MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 35th Annual Canaccord Genuity Growth Conference
Sign up to receive e-mail updates *